WebThe PRS Guided Tutorials provide step-by-step instructions for registering a study, uploading study documents, and submitting results information into the ClinicalTrials.gov PRS. The tutorials also include Quick Overview Guides, a PDF library, annotated figures for various study design examples, and answers to common questions. WebFeb 28, 2024 · NLM Support Center All Browse Help Topics Health Literature Drugs & Medical Devices About NLM & NIH My NCBI/Accounts BLAST Submit Data Genes & Genomes ClinicalTrials.gov Getting NLM Data Grants & Funding History of Medicine Write to the help desk
ClinicalTrials.gov Requirements Human Subjects Office
WebThe ClinicalTrials.gov Protocol Registration and Results System (PRS) is a web-based tool used to submit clinical study information to ClinicalTrials.gov. Records submitted through … WebClinicalTrials.gov is a public registry of clinical trials maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The clinicaltrials.gov website is … linternas trustfire
ClinicalTrials.gov - University of North Carolina at Chapel Hill
WebClinicalTrials.gov: Registering Studies and Submitting Results The following information is provided to help investigators navigate the Protocol Registration and Results System (PRS system) also known as ClinicalTrials.gov. What is ClinicalTrials.gov? What is the definition of a clinical trial? How do I register my study? WebOct 7, 2024 · ClinicalTrials.gov Identifier: NCT05070247 Recruitment Status : Recruiting First Posted : October 7, 2024 Last Update Posted : January 19, 2024 See Contacts and Locations View this study on Beta.ClinicalTrials.gov Sponsor: Takeda Information provided by (Responsible Party): Takeda Study Details Tabular View No Results Posted Disclaimer WebThis has prompted clinical trials evaluating the selective androgen receptor modulator (SARM) enobosarm as monotherapy (Clinicaltrials.gov identifier NCT04869943) and in combination with abemaciclib (Clinicaltrials.gov identifier NCT05065411) in patients who have progressed on ET and a CDK4/6 inhibitor. linternas light painting